Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 2/20 | 0.41 |
| ▸ | PTPRA | P18433 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | FPGS | Q05932 | 2/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1377622 | 0.88 | ALDH1A1 (0.43) | SMN1; SMN2CYP1A2CYP2C19FDPSPTPRA | |
| SCHEMBL5051276 | 0.82 | FOLH1 (0.50) | SMN1; SMN2FOLH1FFAR1 | |
| SCHEMBL2368223 | 0.80 | SMN1; SMN2 (0.42) | SMN1; SMN2CYP1A2CYP2C19FDPSPTPRA | |
| SCHEMBL7609509 | 0.79 | ERAP2 (0.40) | SMN1; SMN2FOLH1RAB9AFPGSFFAR1 | |
| SCHEMBL1376074 | 0.79 | ACE (0.51) | SMN1; SMN2FOLH1 | |
| SCHEMBL7609562 | 0.79 | CYP1A2 (0.40) | CYP1A2FDPSFOLH1 | |
| SCHEMBL2368226 | 0.78 | SMN1; SMN2 (0.43) | SMN1; SMN2CYP1A2CYP2C19FDPSPTPRA | |
| SCHEMBL5059776 | 0.78 | TBXAS1 (0.50) | FDPS | |
| SCHEMBL5053099 | 0.78 | ACE (0.55) | SMN1; SMN2FOLH1 | |
| SCHEMBL7605889 | 0.78 | GGH (0.43) | SMN1; SMN2CYP1A2CYP2C19FDPSPTPRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2002514185-A | — | — | 2002-05-14 | — | — | JP | claimed |
| EP-0949922-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING COMPULSIVE DISORDERS USING NAALADASE INHIBITORS | GUILFORD PHARMACEUTICALS INC. (US) | 1999-10-20 | — | — | EP | claimed |
| WO-1998013044-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING COMPULSIVE DISORDERS USING NAALADASE INHIBITORS | GUILFORD PHARMACEUTICALS INC. (US) | 1998-04-02 | — | — | WO | claimed |